Offer - Urjas Oil for just ₹ 1
Supraglip M is an allopathic medicine The correct dosage of Supraglip M depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Supraglip M is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Is the use of Supraglip M safe for pregnant women?
Supraglip M has little to no side effects in pregnant women.
Is the use of Supraglip M safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of Supraglip M. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of Supraglip M on the Kidneys?
Supraglip M is not harmful for kidneys.
What is the effect of Supraglip M on the Liver?
Supraglip M is completely safe for the liver.
What is the effect of Supraglip M on the Heart?
There are no any side effects of Supraglip M for the heart.
Supraglip M should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Supraglip M unless your doctor advises you to do so -
Is this Supraglip M habit forming or addictive?
Supraglip M does not cause addiction.
Interaction between Food and Supraglip M
Due to a lack of research, nothing can be said about the consequences of taking Supraglip M together with food.
Interaction between Alcohol and Supraglip M
Taking Supraglip M with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 620
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Angiomax® (bivalirudin)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Bivalirudin Apotex (bivalirudin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
